Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease

Geisen, Ulrich; Heilmann, Claudia; Beyersdorf, Friedhelm; Benk, Christoph; Berchtold-Herz, Michael; Schlensak, Christian; Budde, Ulrich; Zieger, Barbara
April 2008
European Journal of Cardio-Thoracic Surgery;Apr2008, Vol. 33 Issue 4, p679
Academic Journal
Abstract: Objective: Outcomes after ventricular assist device (VAD) implantation have significantly improved during the last decade. However, bleeding episodes remain a serious complication of VAD support. This cannot be explained by the individual anticoagulation regimen alone in several cases, but may be symptomatic of acquired von Willebrand disease (VWD). The leading finding in acquired VWD (AVWD) is the loss of large multimers which results in diminished binding to collagen and to the platelets. We, therefore, analysed patients with two VAD types for laboratory parameters of VWD and compared them with patients after heart transplantation (HTX). Materials and methods: Seven patients with a HeartMate II® left-ventricular assist device and five patients who received a Thoratec biventricular assist device were included in this study. Eight HTX recipients served as controls. Analysis included international normalized ratio (INR), partial thromboplastin time (PTT), platelet count, von Willebrand factor (VWF) antigen, collagen binding capacity, ristocetin cofactor activity, the ratios of the latter two to the VWF antigen and presence of large VWF multimers. Results. The VAD and HTX groups did not differ with regard to age or time-point of analysis after surgery. INR and number of platelets were comparable in both groups, PTT was prolonged in VAD patients. Both VAD and HTX patients had elevated but comparable amounts of VWF antigen. However, large multimers were missing in all of 10 tested VAD patients. In contrast, five of six tested HTX recipients displayed normal multimer pattern. Indeed, collagen binding capacity and ristocetin cofactor activity (which measures binding of VWF to platelets) were lower in VAD patients compared to HTX recipients. Impaired coagulation associated with VADs was also reflected by the diminished ratios of collagen binding capacity and ristocetin cofactor activity to VWF antigen. A pathologic collagen binding ratio was found in all 10 tested VAD patients and one of the eight HTX patients, a reduced ristocetin cofactor activity ratio in 10 of 12 VAD and one of eight HTX patients. Conclusion: Non-surgical postoperative bleeding after VAD implantation could be explained by an AVWD. Several pharmacologic treatment options (tranexamic acid, desmopressin, VWF-factor VIII concentrate, recombinant factor VIIa) may arise from our data. Improved VAD design could prevent this problem in the future.


Related Articles

  • Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates Salzberg, Sacha P.; Lachat, Mario L.; von Harbou, Kai; Zünd, Gregor; Turina, Marko I. // European Journal of Cardio-Thoracic Surgery;Feb2005, Vol. 27 Issue 2, p222 

    Abstract: Objective: Pulmonary hypertension (PH) and elevated pulmonary vascular resistance (PVR) lead to poor outcome after heart transplantation due to postoperative failure of the non-conditioned right ventricle. The role of continuous flow left ventricular assist device (LVAD) support in the...

  • Daclizumab prevents rejection but increases the risk of death.  // Reactions Weekly;7/9/2005, Issue 1059, p3 

    Discusses research being done on the association of daclizumab with cellular rejection and increased incidence of death in patients who have undergone heart transplantation. Reference to a study by R. E. Hershberger et al published in the June 30, 2005 issue of the "New England Journal of...

  • Analysis of mitochondrial DNA deletions in four chambers of failing human heart: hemodynamic stress, age, and disease are important factors. Un-Kyung Kim; Hyo-Soo Kim; Byung-Hee Oh; Myoung-Mook Lee; Sung-Han Kim; Jae-Jin Chae; Hyun-Seok Choi; Seong-Choon Choe; Chung-Choo Lee; Young-Bae Park // Basic Research in Cardiology;Mar2000, Vol. 95 Issue 2, p163 

    Mitochondrial DNA (mtDNA) mutations are not only responsible for organ dysfunction due to inefficient energy production but also indicators of metabolic and functional stresses in the organ. To analyze the significance of deletion mutation in human myocardium, we screened the presence of two...

  • FDA clears first blood test for heart transplant patients. YOFFEE, LYNN // Medical Device Daily;9/3/2008, Vol. 12 Issue 189, p1 

    The article reports on the market clearance received by XDx from the U.S. Food and Drug Administration (FDA) for AlloMap Molecular Expression Testing. The blood test is used to aid in the management of heart transplant patients after surgery, which will eliminate the need for endomyocardial...

  • Modified Inferior Vena Caval Anastomosis. Marelli, Daniel; Silvestry, Scott C.; Zwas, Donna; Mather, Paul; Rubin, Sharon; Dempsey, Anthony F.; Stein, Louis; Rodriguez, Evelio; Diehl, James T.; Feldman, Arthur M. // Texas Heart Institute Journal;2007, Vol. 34 Issue 1, p30 

    Postoperative tricuspid valve regurgitation is moderate to severe in 15% to 20% of heart transplant recipients despite use of the bicaval surgical technique. We hypothesized that the regurgitation might be partly due to increased tension on the donor right atrium. To study the right atrial...

  • Role of neuropsychology in evaluation of heart transplant recipients. Davis, J. Mark; Claypoole, Keith H. // Perceptual & Motor Skills;Jun96, Vol. 82 Issue 3, p744 

    Examines the role of neuropsychology in evaluating heart transplant recipients. Case vignettes; Associations among cognitive functioning, emotional status and treatment compliance.

  • Local man needs new heart. Hannigan, Michael V. // Malakoff News (TX);3/14/2008, Vol. 99 Issue 11, p1A 

    The article reports that 61-year-old Jerry Clinard and his family, who are residents of Malakoff, Texas, are asking for financial help to enable him to travel to the Methodist Hospital System in Houston where Clinard will undergo a heart transplant.

  • Heart transplantation is associated with an increased... Vega, Kenneth J.; Pina, Ileana // Annals of Internal Medicine;06/01/96, Vol. 124 Issue 11, p980 

    Presents a study which aims to determine the risk factors for, and, the outcome of pancreaticobiliary disease, in patients who have had an orthotopic heart transplant. Case-patients and controls selected for the study; Matching of controls to case-patients by time of transplantation and length...

  • South African surgeon breaks transplant ban. Sidley, Pat // BMJ: British Medical Journal (International Edition);7/29/95, Vol. 311 Issue 7000, p280 

    Reports on the performance of a heart and lung transplant by heart surgeon Fanus Serfontein despite the implementation of a transplant ban in health system of South Africa. Granting of permission by Gauteng province's superintendent-general Ralph Mgijima; Public assurance on the availability of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics